DrugPatentWatch Database Preview
Details for Patent: 6,641,834
» See Plans and Pricing
Which drugs does patent 6,641,834 protect, and when does it expire?
Patent 6,641,834 protects ALPHAGAN P and is included in two NDAs.
Protection for ALPHAGAN P has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has thirty-eight patent family members in nineteen countries.
Summary for Patent: 6,641,834
| Title: | Compositions containing alpha-2-adrenergic agonist components |
| Abstract: | Compositions useful for improving effectiveness of alpha-2-adrenergic agonist components include carrier components, alpha-2-adrenergic agonist components, solubility enhancing components which aid in solubilizing the alpha-2-adrenergic agonist components. In one embodiment, the alpha-2-adrenergic agonist components include alpha-2-adrenergic agonists. In another embodiment, the solubility enhancing components include carboxymethylcellulose. |
| Inventor(s): | Olejnik; Orest (Coto de Coza, CA), Kerslake; Edward D. S. (Charlestown, MA) |
| Assignee: | Allergan Sales, Inc. (Irvine, CA) |
| Application Number: | 10/236,566 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,641,834 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 6,641,834
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan | ALPHAGAN P | brimonidine tartrate | SOLUTION/DROPS;OPHTHALMIC | 021770-001 | Aug 19, 2005 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||||
| Allergan | ALPHAGAN P | brimonidine tartrate | SOLUTION/DROPS;OPHTHALMIC | 021262-001 | Mar 16, 2001 | AT | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,641,834
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 033539 | Start Trial | |||
| Australia | 2001273269 | Start Trial | |||
| Australia | 2005220199 | Start Trial | |||
| Australia | 2005280259 | Start Trial | |||
| Australia | 2011250793 | Start Trial | |||
| Australia | 7326901 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
